(Press-News.org) A new study led by Hartmut Geiger at the University of Ulm, Germany, and Yi Zheng and Kodandaramireddy Nalapareddy, Cincinnati Children's Hospital Medical Center (CCHMC), USA reveals that age-related changes in the gut microbiota directly impair intestinal stem cell (ISC) function and that restoring a youthful microbial environment can reverse this decline. The results were published today in Stem Cell Reports.
Cells lining the intestine are constantly renewed to maintain tissue integrity, nutrient absorption, and regenerative capacity following injury. This process is driven by ISCs, which divide and mature to produce the cells of the intestinal lining. With aging, ISC activity declines, which contributes to the emergence of age-related intestinal conditions such as impaired nutrient absorption, regenerative capacity, and increased inflammation – key contributors to age-associated intestinal dysfunction.
The researchers found that ISCs in old mice were significantly less active than those in young mice, resulting in diminished intestinal cell replenishment and impaired regeneration after injury. In their new study, the showed that changes in the function of ISCs coincided with pronounced differences in the composition of the gut microbiota between young and aged mice.
To test whether these microbial changes directly influenced stem cell function, the team restored a more youthful microbiota in old mice by transferring gut microbiota from young donors. This intervention reversed the age-related decline in ISC activity, leading to improved regenerative responses following intestinal injury. The researchers further identified a bacterial species enriched in the aged microbiota that appeared to inhibit ISC function, providing mechanistic insight into how specific microbial shifts contribute to stem cell aging.
The findings demonstrate that the gut microbiota are a regulator of intestinal stem cell function and that age-related stem cell decline can be reversible.
The study underscores the microbiota as a critical, modifiable determinant of intestinal homeostasis and tissue regeneration. By linking microbial composition to stem cell activity, the research highlights host-microbe interactions as a potential therapeutic target to preserve intestinal function, enhance regenerative capacity, and promote healthy aging.
About Stem Cell Reports
Stem Cell Reports is the open access, peer-reviewed journal of the International Society for Stem Cell Research (ISSCR) for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians. Stem Cell Reports is a Cell Press partner journal. Find the journal on X: @StemCellReports.
About ISSCR
Across more than 80 countries, the International Society for Stem Cell Research (@ISSCR) is the preeminent global, cross-disciplinary, science-based organization dedicated to advancing stem cell research and its translation to medicine.
END
New study shows gut microbiota directly regulates intestinal stem cell aging
2026-01-22
ELSE PRESS RELEASES FROM THIS DATE:
Leading cancer deaths in people younger than 50 years
2026-01-22
About The Study: Mortality has decreased for every leading cancer-related death in people younger than 50 years in the U.S. except colorectal cancer, which is now the leading cancer death in females and males combined, up from the fifth-leading cancer death in the early 1990s. Breast cancer and leukemia mortality decreased despite increasing incidence.
Authors: Corresponding Author Rebecca Siegel, MPH, is available for interviews 11 AM-5 PM EST Tuesday, January 20. Senior Author Ahmedin Jemal, DVM, PhD, is ...
Rural hospital bypass by patients with commercial health insurance
2026-01-22
About The Study: Rural hospital bypass (when rural residents receive care at hospitals other than their nearest hospital) rates among commercially insured patients were substantial between 2012 and 2021, generating large payments to receiving hospitals. Relative to Medicare bypass rates, commercial bypass rates were high in this sample. The findings of this study support concerns that commercial bypass contributes to financial distress at rural hospitals.
Corresponding Author: To contact the corresponding author, Caitlin E. Carroll, PhD, email carrollc@umn.edu.
To ...
Jumping giants: Fossils show giant prehistoric kangaroos could still hop
2026-01-22
Scientists studying the fossil remains of giant prehistoric kangaroos have found that even animals weighing more than 200kg may not have been too big to bounce, overturning long-held assumptions about the limits of hopping.
Today, the red kangaroo is the largest living hopping animal and weighs around 90kg. But during the Ice Age, some kangaroos grew more than twice the size of that - some reaching up to 250kg.
For years, researchers believed these giants must have abandoned hopping, as earlier studies suggested that hopping would become mechanically ...
Missing Medicare data alters hospital penalties, study finds
2026-01-22
For more than a decade, hospitals have worked to help older adults avoid repeated inpatient stays, incentivized by a federal program that cuts Medicare reimbursements if hospitals have higher-than-expected rates of readmissions for people with certain conditions.
The Hospital Readmissions Reduction Program has helped spur innovation, including initiatives to better prepare patients and their families to manage care after hospitalization, and to support them virtually at home.
But a new University of Michigan study finds that these financial penalties have hit some hospitals harder than they should, even if those hospitals have done a reasonable job at keeping people with heart ...
Experimental therapy targets cancer’s bodyguards, turning foe to friend to eliminate tumors
2026-01-22
[New York, NY [January 22, 2026]—Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells directly, it targets the cells that protect them.
The study, published in the January 22 online issue of Cancer Cell, a Cell Press Journal [DOI 10.1016/j.ccell.2025.12.021], was conducted in aggressive preclinical models of metastatic ovarian and lung cancer. It points to a new strategy ...
Discovery illuminates how inflammatory bowel disease promotes colorectal cancer
2026-01-22
A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone marrow—may help explain why people with inflammatory bowel disease (IBD) have a higher risk of colorectal cancer, according to a preclinical study by Weill Cornell Medicine investigators. The findings point to new possibilities for diagnosis, monitoring and treatment.
The study began with a focus on TL1A, an inflammatory immune signaling protein known to be associated with IBD and colorectal cancer. Experimental drugs that block TL1A activity have shown great promise against IBD in clinical trials, but how the signaling ...
Quality and quantity? The clinical significance of myosteatosis in various liver diseases
2026-01-22
Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of poor clinical outcomes across a spectrum of liver diseases. However, the field faces significant challenges, including a lack of standardized assessment methods, definitions, and diagnostic criteria, as well as an incomplete understanding of its pathophysiological mechanisms. This narrative review aims to synthesize current knowledge on myosteatosis in liver disease, covering its assessment, clinical impact across various etiologies, proposed ...
Expert consensus on clinical applications of fecal microbiota transplantation for chronic liver disease (2025 edition)
2026-01-22
The gut microbiota plays a crucial role in maintaining host health and liver function. Fecal microbiota transplantation (FMT), an emerging therapeutic modality, has demonstrated promising potential in the treatment of chronic liver diseases. To assist clinicians in rapidly mastering and standardizing the clinical application of FMT for chronic liver disease, the Liver-Related Digestive Diseases Group of the Chinese Society of Hepatology, Chinese Medical Association, has developed this expert consensus. The consensus comprehensively addresses key aspects of FMT application, including indications, contraindications, efficacy, safety, donor selection ...
Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor fo
2026-01-22
Presentations include first-in-human Phase 1 results in healthy volunteers, 13-week repeat-dose toxicology in two species, and disease mitigation in a chronic T cell transfer-induced colitis model
CAMBRIDGE, Mass. and SHANGHAI — January 22, 2026 — Insilico Medicine (“Insilico”, HKEX: 03696), a clinical-stage AI-driven biotechnology company, today announced it will present three abstracts at the 2026 Crohn’s & Colitis Congress 2026 in Las Vegas, USA on January 23, 2026 featuring new data supporting the continued development of ISM5411 (also referenced as ISM012-042), an orally administered, gut-restricted small-molecule ...
New imaging technology detects early signs of heart disease through the skin
2026-01-22
Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for invasive procedures. By revealing early signs of cardiovascular risk, this technology could help doctors intervene sooner, guide personalized therapies, and improve long-term heart health.
A New Window Into Microvascular Health
One of the earliest warning signs of cardiovascular disease ...